Cor Vasa 2026, 68(2):143-149 | DOI: 10.33678/cor.2025.094
Study of the Effect of Telecommunication Follow-Up for Patients on Warfarin During the COVID-19 Pandemic
- a Department of Cardiovascular Medicine, Kasr Alainy Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt
- b Sohag Heart and GIT Specialized Center, Sohag, Egypt
Background: Warfarin, a vitamin K antagonist oral anticoagulant, requires frequent monitoring of the international normalized ratio (INR). Telemedicine has emerged as a crucial tool for facilitating remote health- care access, particularly during the COVID-19 pandemic. However, the efficacy and safety of this model for managing warfarin patients in Egypt remain unexplored.
Aim: This study compared telemedicine with conventional warfarin clinic visits regarding achieving target INR and time in therapeutic range (TTR), while assessing differences in expenses and complications.
Methods: Patients receiving warfarin at two tertiary centers in Egypt were randomized into telemedicine or conventional clinic groups. Telemedicine communication utilized telephone and WhatsApp. INR, TTR, cost analysis, and complications were evaluated.
Results: This three-month study included 200 patients. No significant baseline differences existed between groups except for higher smoking rates in the clinic group (40% vs. 24%, p = 0.02). Target TTR (> 70%) was achieved in 78% of clinic patients and 82% of telemedicine patients (p = 0.48). Among patients with baseline INR < 2, target TTR achievement was significantly higher in the telemedicine group (76.5% vs. 30.8%, p < 0.001). Supratherapeutic INR incidence was higher in the clinic group (40% vs. 20%, p = 0.002). No significant differences in bleeding or thrombotic events occurred between groups. Telemedicine services demonstrated significantly lower costs than conventional clinics.
Conclusion: Telecommunication offers a feasible alternative for warfarin management with comparable efficacy and safety in both urban and rural areas. This method significantly reduces cost burden on healthcare facilities and patients. We recommend adopting standardized telecommunication methods on a broader scale in Egyptian clinical practice.
Keywords: INR, Telemedicine, TTR, Warfarin,
Received: August 8, 2025; Revised: August 8, 2025; Accepted: September 1, 2025; Prepublished online: June 2, 2012; Published: May 20, 2026 Show citation
References
- Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e44S-e88S.
Go to original source... - Ansell J, Hirsh J, Hylek J, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):160S-198S.
Go to original source... - World Health Organization. Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth. Geneva: World Health Organization; 2010. Online. Available from: https://apps.who.int/iris/handle/10665/44497. [cited 2026-05-10].
- Al-Samarraie H, Al-Rahmi WM, Al-Sharafi A, et al. The impact of telemedicine on healthcare quality and patient satisfaction: a systematic review. J Telemed Telecare 2023;29:3-17.
- Bashshur RL, Shannon GW, Smith BR, et al. Telemedicine and health care reform. Telemed J E Health 2011;17:483-490.
Go to original source... - Monaghesh E, Ramezani A. The role of telemedicine during COVID-19 pandemic: a systematic review. Telemed J E Health 2020;26:599-606.
- Chu C, Cram P, Pang A, et al. Rural Telemedicine Use Before and During the COVID-19 Pandemic: Repeated Cross-sectional Study. J Med Internet Res 2021;23:e26960.
Go to original source... - Akuana CM, Mohammadnezhad M. Utilization and impact of telemedicine among individuals in Egypt: a systematic review. MOJ Public Health 2025;14:59-65.
Go to original source... - Combi C, Pozzani G, Pozzi G. Telemedicine for Developing Countries. A Survey and Some Design Issues. Appl Clin Inform 2016;7:1025-1050.
Go to original source... - Ministry of Communications and Information Technology, Egypt. Digital Egypt Strategy 2030. Online. Available from: https://www.mcit.gov.eg/en/Digital_Egypt_Strategy_2030. [cited 2026-05-10].
- Sakunrag I, Danwilai K, Dilokthornsakul P, et al. Clinical outcomes of telephone service for patients on warfarin: a systematic review and meta-analysis. Telemed J E Health 2020;26:1507-1521.
Go to original source... - Bernstein MR, John L, Sciortino S, et al. Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project. J Thromb Thrombolysis 2020;49:316-320.
Go to original source... - Prochaska JH, Gobel S, Keller K, et al. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service - results from the prospective, multi-center, observational cohort study thrombEVAL. BMC Med 2015;13:14.
Go to original source... - Mars M. Medicolegal, ethical, and regulatory guidelines pertaining to telehealth. In: Fundamentals of Telemedicine and Telehealth. 2020:297-303.
Go to original source... - Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F. Standardization of Prothrombin Time/International Normalized Ratio (PT/INR). Int J Lab Hematol 2021;43:21-28.
Go to original source... - Rosendaal FR, Cannegieter ER, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;70:103-107.
Go to original source... - Hylek EM, Skates SJ, Sheehan PA, Singer DE. An analysis of the quality of anticoagulation in a community-based cohort of patients with atrial fibrillation. Stroke 2003;34:2653-2658.
- Van Gelder IC, Rienstra M, V Bunting K, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J 2024;45:3314-3414.
Go to original source... - Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 2020;21:543-603.
Go to original source... - Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2022;43:561-632.
Go to original source... - Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Definition of major bleeding in clinical trials of antithrombotic agents in surgical patients. J Thromb Haemost 2005;3:692-694.
Go to original source... - Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 2019;78:1296-1304.
Go to original source... - Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-2747.
- National Clinical Guideline Centre (UK). Atrial Fibrillation: The Management of Atrial Fibrillation. London: National Institute for Health and Care Excellence (UK) (2014).
- Mearns ES, White CM, Kohn CG, et al. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thrombosis J 2014;12:1-20.
Go to original source... - Haas S, Ten Cate H, Accetta G, et al. Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry. PLoS One 2016;11:e0164076.
Go to original source... - Jiang S, Lv M, Zeng Z, et al. Efficacy and safety of app based remote warfarin management during COVID 19 related lockdown: a retrospective cohort study. J Thromb Thrombolysis 2022;54:20-28.
Go to original source... - Shambu SK, Shetty SP, Gona OJ, et al. Implementation and Evaluation of Virtual Anticoagulation Clinic Care to Provide Incessant Care During COVID-19 Times in an Indian Tertiary Care Teaching Hospital. Front Cardiovasc Med 2021;8:648265.
Go to original source... - Alanazi Z, Almutairi N, AlDukkan L, et al. Time in therapeutic range for virtual anticoagulation clinic versus in-person clinic during the COVID-19 pandemic: a crossover study. Ann Saudi Med 2022;42:305-308.
Go to original source... - Hawes EM, Lambert E, Reid A, et al. Implementation and evaluation of a pharmacist-led electronic visit program for diabetes and anticoagulation care in a patient-centered medical home Am J Health Syst Pharm 2018;75:901-910.
Go to original source... - Al Ammari M, AlThiab K, AlJohani M, et al. Tele-pharmacy anticoagulation clinic during COVID-19 pandemic: patient outcomes. Front Pharmacol 2022;12:652482.
Go to original source... - Singh G, Kapoor S, Bansal V, et al. Active surveillance with telemedicine in patients on anticoagulants during the national lockdown (COVID- 19 phase) and comparison with pre-COVID-19 phase. Egypt Heart J 2020;72:70.
Go to original source... - Braga Ferreira L, Lanna de Almeida R, Arantes A, et al. Telemedicine-Based Management of Oral Anticoagulation Therapy: Systematic Review and Meta-analysis. J Med Internet Res 2023;25:e45922.
Go to original source... - Eggebrecht L, Ludolph P, Göbel S, et al. Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: results from the thrombEVAL study. Sci Rep 2021;11:2577.
Go to original source...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.




